Russo, Marcos Guillermo 
; Brusau, Elena Virginia; Ellena, Javier ; Narda, Griselda Edith
Fonte: International Journal of Pharmaceutics. Unidade: IFSC
Assuntos: ANTI-HISTAMÍNICOS H2, CRISTALOGRAFIA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Marcos Guillermo et al. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution. International Journal of Pharmaceutics, v. 642, p. 123053-1-123053-10 + supplementary material, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123053. Acesso em: 08 out. 2025.APA
Russo, M. G., Brusau, E. V., Ellena, J., & Narda, G. E. (2023). Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution. International Journal of Pharmaceutics, 642, 123053-1-123053-10 + supplementary material. doi:10.1016/j.ijpharm.2023.123053NLM
Russo MG, Brusau EV, Ellena J, Narda GE. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution [Internet]. International Journal of Pharmaceutics. 2023 ; 642 123053-1-123053-10 + supplementary material.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123053Vancouver
Russo MG, Brusau EV, Ellena J, Narda GE. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution [Internet]. International Journal of Pharmaceutics. 2023 ; 642 123053-1-123053-10 + supplementary material.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123053
